VPIM
ABMD

Vanguard Personalized Indexing Management’s Abiomed Inc ABMD Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,641
Closed -$1.63M – 1366
2022
Q3 		$1.63M Buy
6,641
+298
+5% +$80.5K 0.07% 280
2022
Q2 		$1.57M Buy
6,343
+629
+11% +$170K 0.07% 268
2022
Q1 		$1.89M Buy
5,714
+2,500
+78% +$770K 0.09% 206
2021
Q4 		$1.15M Buy
3,214
+170
+6% +$57.4K 0.07% 322
2021
Q3 		$991K Buy
3,044
+671
+28% +$227K 0.09% 225
2021
Q2 		$741K Buy
2,373
+1,452
+158% +$445K 0.08% 321
2021
Q1 		$294K Sell
921
-51
-5% -$16.3K 0.04% 512
2020
Q4 		$315K Sell
972
-21
-2% -$5.81K 0.07% 352
2020
Q3 		$275K Buy
+993
New +$286K 0.08% 317

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Vanguard Personalized Indexing Management's ABMD Position: Q4 2022 in Review

Vanguard Personalized Indexing Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,641 shares — an estimated $1.63M sold.

Vanguard Personalized Indexing Management first reported a position in ABMD in Q3 2020 and held it in 9 quarters. The position peaked at $1.89M in Q1 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Vanguard Personalized Indexing Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Vanguard Personalized Indexing Management sold 6,641 Abiomed Inc shares in Q4 2022, an estimated $1.63M.
  • Vanguard Personalized Indexing Management first reported a position in Abiomed Inc in Q3 2020 and held it in 9 quarters.
  • Vanguard Personalized Indexing Management's Abiomed Inc position peaked at $1.89M in Q1 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Vanguard Personalized Indexing Management's 13F filing for Q4 2022, filed 10 Feb 2023.